Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey.
Department of Biochemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey.
Bioorg Chem. 2020 Aug;101:104028. doi: 10.1016/j.bioorg.2020.104028. Epub 2020 Jun 18.
A new series of pyrimidine derivatives containing aryl urea moieties was designed and synthesized. The anticancer activities of all compounds were evaluated in vitro against colon and prostat cancer cell lines by MTT assay. Among these compounds, 4b exhibited the highest cytotoxic activity against SW480 cancer cell line with IC value of 11.08 µM. Mechanistic studies showed that compound 4b arrested cell cycle at G2/M phase and induced apoptosis through upregulating Bax, Ikb-α and cleaved PARP and downregulating Bcl-2 expression levels. Moreover, compound 4b induced loss of mitochondrial membrane potential in SW480 cells. These results suggest that pyrimidine with urea moieties could be a template for designing new anticancer agents.
设计并合成了一系列含有芳基脲部分的嘧啶衍生物。采用 MTT 法测定了所有化合物对结肠和前列腺癌细胞系的体外抗癌活性。在这些化合物中,4b 对 SW480 癌细胞系表现出最高的细胞毒性,IC 值为 11.08 µM。机制研究表明,化合物 4b 通过上调 Bax、Ikb-α 和 cleaved PARP 以及下调 Bcl-2 表达水平,将细胞周期阻滞在 G2/M 期,并诱导细胞凋亡。此外,化合物 4b 诱导 SW480 细胞中线粒体膜电位丧失。这些结果表明,带有脲基的嘧啶可以作为设计新型抗癌药物的模板。